PEPTIDES FOR THE TREATMENT OF RESPIRATORY INFECTIONS OF VIRAL ORIGIN

Peptides that have an amino acid sequence selected from the group consisting of SEQ ID NO: 2 to SEQ ID NO: 20, as well as pharmaceutical compositions comprising said peptides. Pharmaceutical composition for the treatment or prevention of infections caused by viruses that infect epithelial cells of t...

Full description

Saved in:
Bibliographic Details
Main Authors RAMÍREZ SUÁREZ, Anna, PERERA GONZÁLEZ, Carmen, FERNÁNDEZ ORTEGA, Celia, CASILLAS CASANOVA, Dionne, ÁLVAREZ PÉREZ, Karen, RODRIGUEZ MOLTO, María, UBIETA GÓMEZ, Raimundo, PEREA RODRÍGUEZ, Silvio, FALCON CAMA, Viviana, DUARTE CANO, Carlos, GUILLEN NIETO, Gerardo, CABRALES RICO, Ania, GARAY PÉREZ, Hilda
Format Patent
LanguageEnglish
Published 24.10.2024
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Peptides that have an amino acid sequence selected from the group consisting of SEQ ID NO: 2 to SEQ ID NO: 20, as well as pharmaceutical compositions comprising said peptides. Pharmaceutical composition for the treatment or prevention of infections caused by viruses that infect epithelial cells of the mammalian respiratory system, comprising a peptide that has an amino acid sequence identified as SEQ ID NO: 1. The invention includes the use of peptides that have an amino acid sequence identified as SEQ ID NO: 1 to SEQ ID NO: 20 for the manufacture of a medicament for the treatment or prevention of infections caused by viruses that infect epithelial cells of the mammalian respiratory system. Also disclosed is a combination of at least one peptide of amino acid sequence identified as SEQ ID NO: 1 to SEQ ID NO: 20 with an antiviral medication.
Bibliography:Application Number: AU20210406354